High-dose naloxone in tardive dyskinesia

[1]  M. E. Lewis,et al.  Anatomy of the CNS opioid systems , 1985, Trends in Neurosciences.

[2]  I. Izquierdo,et al.  Role of β‐Endorphin in Behavioral Regulation a , 1985 .

[3]  P. Spano,et al.  Dopamine enhances Met-enkephalin efflux from rat striatal slices , 1984, Brain Research.

[4]  M. Gallagher,et al.  Opiate antagonists improve spatial memory. , 1983, Science.

[5]  D. Hommer,et al.  The actions of opiates in the rat substantia nigra: An electrophysiological analysis , 1983, Peptides.

[6]  B. Reisberg,et al.  Effects of naloxone in senile dementia: a double-blind trial. , 1983, New England Journal of Medicine.

[7]  T. Cooper,et al.  Naloxone, tardive dyskinesia, and endogenous beta-endorphin , 1982, Psychiatry Research.

[8]  M. Gallagher.  Naloxone enhancement of memory processes: effects of other opiate antagonists. , 1982, Behavioral and neural biology.

[9]  W. Verhoeven,et al.  Short-term naloxone administration in schizophrenic and manic patients. A World Health Organization Collaborative Study. , 1982, Archives of general psychiatry.

[10]  R. Zukin,et al.  Demonstration of [3H]cyclazocine binding to multiple opiate receptor sites. , 1981, Molecular pharmacology.

[11]  H. Rigter,et al.  Endorphins alter acquisition and consolidation of an inhibitory avoidance response in rats , 1980, Neuroscience Letters.

[12]  J. Nazzaro,et al.  Selective inhibition of mesolimbic behavioral supersensitivity by naloxone. , 1980, European journal of pharmacology.

[13]  J. D. McGaugh,et al.  Naloxone enhancement of memory. , 1979, Behavioral and neural biology.

[14]  K. Carlson,et al.  Time course of dopaminergic hypersensitivity following chronic narcotic treatment , 1979, Pharmacology Biochemistry and Behavior.

[15]  A. Herz,et al.  In vivo receptor occupation by opiates and correlation to the pharmacological effect. , 1978, Federation proceedings.

[16]  E. J. Simon,et al.  In vitro studies on opiate receptors and their ligands. , 1978, Federation proceedings.

[17]  H. Emrich,et al.  Indication of an Antipsychotic Action of the Opiate Antagonist Naloxone , 1977, Pharmakopsychiatrie, Neuro-Psychopharmakologie.

[18]  J. Schwartz,et al.  Enkephalin receptors on dopaminergic neurones in rat striatum , 1977, Nature.

[19]  R. Baldessarini,et al.  Pathophysiologic basis of tardive dyskinesia. , 1977, Advances in biochemical psychopharmacology.

[20]  H. Y. Yang,et al.  On the locaticn of methicnine enkephalin neurons in rat striatum , 1977, Neuropharmacology.

[21]  Choh Hao Li,et al.  β-Endorphin in vitro inhibition of striatal dopamine release , 1976, Nature.

[22]  S. Snyder,et al.  Opiate receptor: autoradiographic localization in rat brain. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[23]  L. Terenius,et al.  Increased CSF levels of endorphines in chronic psychosis , 1976, Neuroscience Letters.

[24]  V. Garsky,et al.  Enkephalin-stimulated prolactin release. , 1976, Life sciences.

[25]  S. Snyder,et al.  The regional distribution of a morphine-like factor enkephalin in monkey brain , 1976, Brain Research.

[26]  J. Korf,et al.  Influence of drugs on striatal and limbic homovanillic acid concentration in the rat brain. , 1975, European journal of pharmacology.

[27]  H. Lal,et al.  A comparison of narcotic analgesics with neuroleptics on behavioral measures of dopaminergic activity. , 1975, Life sciences.

[28]  HERMAN BUSCHKE,et al.  Evaluating storage, retention, and retrieval in disordered memory and learning , 1974, Neurology.

[29]  S. Snyder,et al.  Regional Distribution of Opiate Receptor Binding in Monkey and Human Brain , 1973, Nature.

[30]  O. Hornykiewicz,et al.  Morphine catalepsy in the rat: relation to striatal dopamine metabolism. , 1972, European journal of pharmacology.

[31]  M. H. Aprison.  Advances in biochemical psychopharmacology: Volume 1, edited by E. Costa and P. Greengard, Raven press (1969) , 1970 .

[32]  G. Crane.  Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature. , 1968, The American journal of psychiatry.

[33]  J. Overall,et al.  The Brief Psychiatric Rating Scale , 1962 .

[34]  S. Snider,et al.  Naloxone treatment of L-dopa-induced dyskinesias in Parkinson's disease. , 1986, The American journal of psychiatry.

[35]  Mm. Liabre.  Standard Progressive Matrices , 1984 .

[36]  K. Mueser,et al.  Narcotic Antagonists in Schizophrenia: A Methodological Review , 1983 .

[37]  H. Akil,et al.  The effects of naloxone in chronic schizophrenia. , 1981, The American journal of psychiatry.

[38]  A. Luria.  Higher Cortical Functions in Man , 1980, Springer US.

[39]  R. Herning,et al.  Naloxone-induced mood and physiologic changes in normal volunteers , 1979 .

[40]  L. G. Davis,et al.  Endorphins, dopamine, and schizophrenia. , 1979, Schizophrenia bulletin.

[41]  D. Wechsler.  The measurement and appraisal of adult intelligence, 4th ed. , 1958 .